Congress Considering Five New Bills Targeting China Stocks & Bonds
These 5 bills have the potential of dealing a debilitating blow to Wall Street’s underwriting of CCP-controlled companies.
Economic View: Productivism is the Key to National Prosperity
US productivity growth has underperformed since the year 2000.
Mexico’s Violation of Steel Import Agreement is Threatening Local U.S. Economies
Steel imports from Mexico have surged far above historic levels, violating Mexico’s trade agreement with the U.S. and threatening local U.S. economies.
CPA Member Atlas Tool Works Awarded Northrop Grumman’s Supplier Excellence Award
“Atlas Tool Works has helped to advance national security solutions and achieve mission success,” said Matt Bromberg, Corporate Vice President, Global Operations Northrop Grumman.
Job Quality Index Down, Manufacturing Job Growth Flat Despite 303,000 Jobs Added Nationwide
CPA Job Quality Index: Despite the federal government’s strong March 2024 Jobs Report released last Friday, the JQI shows the US labor market suffers from persistent structural issues.
Has Janet Yellen Seen the Light on China?
Treasury Secretary Janet Yellen just spent the weekend in China, her second trip there in less than a year.
Goods Deficit Flat at $91.4 Billion in February, As Mexico Takes Over China’s Position as Top Source of Imports
While the month-over-month goods deficit with China fell by around $3.7 billion, the deficit with Mexico rose by $2 billion over the same period.
Gas, Eggs, and Airline Tickets Rose Over 30% During Inflation Spike. Tariffs Had Nothing To Do With It.
Energy prices, food prices, and price spikes due to shortages were the dominant drivers of inflation.
CPA Applauds Call from Senators Brown, Vance, Casey that Biden Block Nippon Steel Acquisition
Senators Brown, Vance, and Casey are right to sound the alarm on why Nippon’s acquisition of U.S. Steel poses a serious threat to American national and economic security.
America’s Life-Threatening Drug Shortages Reach Record Highs
Despite spending over $600 billion on prescription drugs, the number of drugs in shortage rose to a near-record total of 301 active medication shortages at the end of 2023.
